Viewing Study NCT06374602


Ignite Creation Date: 2025-12-25 @ 3:38 AM
Ignite Modification Date: 2025-12-26 @ 2:22 AM
Study NCT ID: NCT06374602
Status: RECRUITING
Last Update Posted: 2025-09-05
First Post: 2024-03-27
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Efficacy of Pembrolizumab and Lenvatinib in Patients With Anaplastic Thyroid Cancer
Sponsor: Saint Petersburg State University, Russia
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module